Selective Fluorination of Adamantanes by an Electrochemical
Method
Motoshi Aoyama, Tsuyoshi Fukuhara, and Shoji Hara*
Graduate School of Engineering, Hokkaido UniVersity, Sapporo 060-8628, Japan
ReceiVed March 9, 2008
Selective fluorination of adamantanes was achieved by the electrochemical fluorination method, using
Et3N-5HF as electrolyte and a fluorine source. Mono-, di-, tri-, and tetrafluoroadamantanes were selectively
prepared from adamantanes by controlling the oxidation potential, and the fluorine atoms were introduced
selectively at the tertiary carbons. Adamantanes that have functional groups such as ester, cyano, and
acetoxymethyl were also fluorinated selectively.
Introduction
fluoroadamantanes because its starting materials are easily
available. However, for the direct fluorination of the adaman-
tanes, strong oxidizing reagents, such as F2, are generally
required, which are generally hazardous and require special skill
to use. Moreover, their high reactivity causes a low selectivity
of the reaction, which makes it difficult to introduce fluorine
atoms only at the desired positions by the direct method.6a,d,e,g,h
Therefore, the fluorinated analogues of the aminoadamantane
were synthesized via the deoxyfluorination reaction from the
corresponding hydroxy compounds,3b,c which is a more reliable
and safer way than the direct method, although it requires a
multistep process. Recently, an electrochemical fluorination
reaction with Et3N-5HF as a fluorine source and an electrolyte
has been developed as a useful method for the partial fluorination
of organic compounds.7 There are three advantages of using
the electrochemical fluorination method with Et3N-5HF. (1)
The oxidation potential can be controlled precisely by using
Adamantane (C10H16) is a simple tricyclic cage compound
consisting of only two kinds of carbons: four tertiary carbons
and six secondary carbons. Adamantane derivatives such as
aminoadamantanes are known to have interesting biological
properties,1 and 1-aminoadamantane (amantadine) and 3,5-
dimethyl-1-aminoadamantane (memantine) are used as medi-
cines for treating influenza, Parkinson’s disease, and Alzheimer’s
disease. As the introduction of fluorine atoms into bioactive
compounds can enhance or modify their activities,2 preparation
of fluorine derivatives has attracted the attention of organic and
medicinal chemists.3 Fluorination of adamantanes has been
carried out through the deoxyfluorination of adamantanols,4
halogen exchange reaction from other haloadamantanes,5 or
direct fluorination of the adamantane itself.6 Among them, the
direct fluorination method is preferable for the synthesis of the
(1) Wishnok, J. S. J. Chem. Educ. 1973, 50, 780.
(2) Welch, J. T. Tetrahedron 1987, 43, 3123.
(5) (a) Bhandari, K. S.; Pincock, R. E. Synthesis 1974, 655. (b) Rozen, S.;
Brand, M. J. Org. Chem. 1981, 46, 733. (c) Olah, G. A.; Shih, J. G.; Singh,
B. P.; Gupta, B. G. B. Synthesis 1983, 713. (d) Olah, G. A.; Shih, J. G.;
Krishnamurthy, V. V.; Singh, B. P. J. Am. Chem. Soc. 1984, 106, 4492. (e)
Della, E. W.; Head, N. J. J. Org. Chem. 1992, 57, 2850. (f) Della, E. W.; Head,
N. J.; Janowski, W. K.; Schiesser, C. H. J. Org. Chem. 1993, 58, 7876. (g)
Leroux, F.; Garamszegi, L.; Schlosser, M. J. Fluorine Chem. 2002, 117, 177.
(6) (a) Barton, D. H. R.; Hesse, R. H.; Markwell, R. E.; Pechet, M. M.; Toh,
H. T. J. Am. Chem. Soc. 1976, 98, 3034. (b) Olah, G. A.; Shih, J. G.; Singh,
B. P.; Gupta, B. G. B. J. Org. Chem. 1983, 48, 3356. (c) Gal, C.; Rozen, S.
Tetrahedron Lett. 1985, 26, 2793. (d) Zajc, B.; Zupan, M. Bull. Chem. Soc.
Jpn. 1986, 59, 1659. (e) Brower, K. R. J. Org. Chem. 1987, 52, 798. (f) Rozen,
S.; Gal, C. J. Org. Chem. 1988, 53, 2803. (g) Stavber, S.; Zupan, M. Tetrahedron
1989, 45, 2737. (h) Chambers, R. D.; Kenwright, A. M.; Parsons, M.; Sandford,
G.; Moilliet, J. S. J. Chem. Soc., Perkin Trans. 2002, 1, 2190.
(3) (a) Samnick, S.; Ametamey, S.; Gold, M. R.; Schubiger, P. A. J. Labelled
Compd. Radiopharm. 1997, 39, 241. (b) Jasys, V. J.; Lombardo, F.; Appleton,
T. A.; Bordner, J.; Ziliox, M.; Volkmann, R. A. J. Am. Chem. Soc. 2000, 122,
466. (c) Kolocouris, A.; Hansen, R. K.; Broadhurst, R. W. J. Med. Chem. 2004,
47, 4975.
(4) (a) Olah, G. A.; Nojima, M.; Kerekes, I. Synthesis 1973, 786. (b) Olah,
G. A.; Welch, J. T.; Vankar, Y. D.; Nojima, M.; Kerekes, I.; Olah, J. A. J. Org.
Chem. 1979, 44, 3872. (c) Adcock, W.; Kok, G. B. J. Org. Chem. 1987, 52,
356. (d) Kanie, K.; Tanaka, Y.; Shimizu, M.; Kuroboshi, M.; Hiyama, T. Chem.
Commun. 1997, 309. (e) Kanie, K.; Tanaka, Y.; Suzuki, M.; Kuroboshi, M.;
Hiyama, T. Bull. Chem. Soc. Jpn. 2000, 73, 471. (f) Petrov, V. A.; Swearingen,
S.; Hong, W.; Petersen, W. C. J. Fluorine Chem. 2001, 109, 25. (g) Bucsi, I.;
To¨ro¨k, B.; Marco, A. I.; Rasul, G.; Prakash, G. K. S.; Olah, G. A. J. Am. Chem.
Soc. 2002, 124, 7728.
4186 J. Org. Chem. 2008, 73, 4186–4189
10.1021/jo8004759 CCC: $40.75 2008 American Chemical Society
Published on Web 05/07/2008